Rimegepant shows efficacy in migraine prevention
The migraine treatment rimegepant also appears to have efficacy in preventing migraines, researchers reported on Dec. 15, 2020 in The Lancet.
The migraine treatment rimegepant also appears to have efficacy in preventing migraines, researchers reported on Dec. 15, 2020 in The Lancet.
Author: Gary Finnegan A ‘brain training’ game developed by researchers at the University of Cambridge, UK, could help improve the memory of patients in the very earliest stages… read more.
by Bruce Sylvester: Ketamine reduced suicidal thoughts in a small group of patients with treatment-resistant depression, researchers reported on May 10, 2016 in the Journal of Clinical Psychiatry.
by Gary Finnegan: A new study shows that while suicide in new mothers is rare, the link with postpartum psychiatric disorders is strong.
by Bruce Sylvester: Smoking cessation treatment with varenicline and bupropion does increase serious neuropsychiatric side effects, researchers reported in The Lancet on April 22, 2016.
by Bruce Sylvester: Hyrdomorphone, a licensed pain medication, shows efficacy in treating chronic heroin addiction, researchers from the SALOME (the Study to Assess Longer-term Opioid Medication Effectiveness) trial… read more.
A group of drugs being developed to treat mood disorders could also relieve chronic pain, finds new UCL (University College London) research funded by the Medical Research Council.
by Bruce Sylvester: Treatment with oxytocin, a synthetic hormone, significantly improved social, emotional and behavioral parameters among children with autism, researchers reported on Oct. 27, 2015 in Molecular… read more.
by Bruce Sylvester: Patients with depression or anxiety who were prescribed opioids for chronic lower back pain have achieved significantly less pain relief and were more likely to… read more.
Schizophrenia, which affects 2 million to 3 million people in the U.S., causes hallucinations, delusions and disorganization. Left untreated, the disease can cause a significant loss in quality… read more.
by Bruce Sylvester: Menopausal women having difficulty with time management, attention, organization, memory, and problem solving (also known as “executive functions”) appear to benefit from treatment with lisdexamfetamine,… read more.
by Bruce Sylvester: Treatment with the growth hormone growth factor-1 (IGF-1) significantly improves social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome,… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.